3. quarter results 2010 for MediStim ASA

Revenue for the 3rd quarter was MNOK 36.6 (MNOK 39.5)
with a profit before tax of MNOK 6.6 (MNOK 8.9). The
company has a strong cash flow from operation. Sales
through own sales organization was strong with a 13 %
volume growth in the US and 29 % volume growth in
Germany. During the quarter the company filed its
application to US FDA for VeriQC.